Stocks Soar 12% As Growth in U.S. COVID-19 Cases Slows

April 9, 2020

In this strategy briefing…

Up and down, and then up and down some more. So goes the U.S. stock market amid continuing investor anxiety and confusion over the economic effects of the coronavirus (COVID-19) pandemic. Tens of thousands around ... – The Wall Street DebriefRead more
Last week’s message from both NY (the epicenter) and the White House is that COVID-19 is on track to undershoot "peak" utilization of the healthcare system, a critical development. NY State does indeed seem to be moving – Tom Lee's Equity StrategyRead more
Federal Reserve policymakers were out on the hustings last week, and they continued to emphasize more aid may be needed on the fiscal front, especially in terms of credit to small firms and people most affected. Thursday, ... – Fed WatchRead more

FS Insight Investment Views

Near Term View: Major COVID-19 Case Deceleration, Curve Flattening Seen, Case peak remains key bogey for markets.
‘20 Target: 3,450 (YE P/E 17.9x · 2021 EPS $193)
Style: High Quality
Granny shots: GOOG, AAPL, AMP, PYPL, NVDA, CSCO, XLNX, FB, MNST, VRSN, DE, QCOM, KSU, EXPE, MXIM, MSFT, TTWO, ROK, DOV, PSX, BKNG, EBAY, EMR, TSLA, AXP, BF/B, PM, GRMN
Disclosures (show)

Sign in to read the report!

We have detected you are an active member!

Ray: 30f886-168573-4a39f2-b1ca6b-006cca

Want to receive Regular Market Updates to your Inbox?

I am your default error :)

Events

Trending tickers in our research